Tekla Life Sciences Investors Declares Distribution
May 15 2023 - 10:36AM
Business Wire
On May 15, 2023, Tekla Life Sciences Investors declared a
distribution of $0.32 per share. The record date for the
distribution is May 25, 2023 and the payable date is June 30, 2023.
The Fund will trade ex-distribution on May 24, 2023.
Under its distribution policy, the Fund intends to make
quarterly distributions at a rate of 2% of the Fund’s net assets.
Therefore, when the net assets of the Fund are down, the
distribution per share amount will decrease and when the net assets
are up, the distribution amount per share will increase. This
distribution will automatically be paid in newly issued shares of
the Fund unless otherwise instructed by the shareholder. The shares
will be valued at the lower of the net asset value or market price
on the pricing date, June 22, 2023. Fractional shares will
generally be settled in cash, except for registered shareholders
with book entry accounts at the transfer agent who will have whole
and fractional shares added to their account.
Shareholders may request to be paid in cash instead of shares by
responding to the bank, brokerage or nominee who holds the shares
if the shares are in “street name” or by filling out an election
card received from Computershare Investor Services shortly after
the record date if the shares are in registered form. The bank,
brokerage or nominee who holds the shares must advise the
Depository Trust Company ("DTC") as to their full and fractional
share requirements by June 21, 2023. Written notification for the
election of cash instead of stock by registered shareholders must
be received by Computershare Investor Services prior to June 21,
2023.
Tekla Life Sciences Investors (NYSE: HQL) is a closed-end fund
that invests in public and private companies in the life sciences
industry. Tekla Capital Management LLC, based in Boston, serves as
Investment Adviser to the Fund. Shares of the Fund can be purchased
on the New York Stock Exchange through any securities broker.
Information regarding the Fund and Tekla Capital Management LLC
can be found at www.teklacap.com.
Please contact Destra Capital Advisors, the Fund’s marketing and
investor support services agent, at HQL@destracapital.com or call
(877)855-3434 if you have any questions regarding HQL.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230515005599/en/
Destra Capital Advisors HQL@destracapital.com (877)855-3434
abrdn Life Sciences Inve... (NYSE:HQL)
Historical Stock Chart
From Apr 2024 to May 2024
abrdn Life Sciences Inve... (NYSE:HQL)
Historical Stock Chart
From May 2023 to May 2024